Home » UCB Studying Cimzia for Another Use
UCB Studying Cimzia for Another Use
UCB recently reported positive results from a late-stage study on Cimzia (certolizumab pegol) in adult patients with active axial spondyloarthritis. The study was conducted to evaluate the efficacy and safety of the drug.
Zacks
Zacks
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May